CINECA IRIS Institutional Research Information System

GUERRINI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.604
EU - Europa 2.069
AS - Asia 986
AF - Africa 94
SA - Sud America 25
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.799
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.509
IT - Italia 793
CN - Cina 511
SE - Svezia 482
GB - Regno Unito 231
BG - Bulgaria 172
SG - Singapore 172
DE - Germania 169
VN - Vietnam 112
TR - Turchia 96
CA - Canada 92
CI - Costa d'Avorio 54
FI - Finlandia 52
UA - Ucraina 33
FR - Francia 30
RU - Federazione Russa 30
BE - Belgio 28
SN - Senegal 26
BR - Brasile 23
HK - Hong Kong 20
AU - Australia 18
IN - India 17
KR - Corea 17
PH - Filippine 16
CH - Svizzera 12
JP - Giappone 11
ES - Italia 9
NG - Nigeria 9
NL - Olanda 6
CZ - Repubblica Ceca 5
GR - Grecia 4
EU - Europa 3
MY - Malesia 3
BD - Bangladesh 2
BT - Bhutan 2
DK - Danimarca 2
HR - Croazia 2
IE - Irlanda 2
LT - Lituania 2
MX - Messico 2
PL - Polonia 2
TH - Thailandia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BJ - Benin 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
IR - Iran 1
PA - Panama 1
RO - Romania 1
UY - Uruguay 1
VE - Venezuela 1
Totale 6.799
Salva come PNG Salva come JPEG
Città #
Serra 388
Woodbridge 365
Fairfield 359
Santa Clara 323
Ann Arbor 271
Houston 267
Chandler 260
Ashburn 205
Seattle 193
Sofia 170
Beijing 146
Wilmington 146
Shanghai 141
Cambridge 125
New York 106
Milan 97
Boardman 91
Princeton 86
Singapore 82
Ottawa 76
London 65
Florence 62
Medford 60
Izmir 59
Lawrence 59
Abidjan 54
Jacksonville 42
Des Moines 41
Dearborn 35
Nanjing 35
Istanbul 30
Dong Ket 27
San Diego 27
Dakar 26
Brussels 23
Lancaster 23
Pisa 23
Bremen 20
Hong Kong 20
Redwood City 20
Nanchang 19
Rome 18
Los Angeles 14
Shenyang 13
Alessandria 12
Changsha 11
Fuzhou 11
Hefei 10
Manila 10
Duncan 9
Frankfurt am Main 9
Lagos 9
Bern 8
Hebei 8
Jüchen 8
Melbourne 8
Boulder 7
Dallas 7
Jiaxing 7
Kunming 7
Norwalk 7
Cascina 6
Chengdu 6
Düsseldorf 6
Falls Church 6
Hangzhou 6
Helsinki 6
Nürnberg 6
Perth 6
Phoenix 6
Tianjin 6
Washington 6
Westminster 6
Zhengzhou 6
Charlottetown 5
East Lansing 5
Palermo 5
Quanzhou 5
Seocho-gu 5
Guangzhou 4
Leawood 4
Leeds 4
Livorno 4
Ogden 4
Seongnam-si 4
Toronto 4
Auburn Hills 3
Aydin 3
Changchun 3
Chiavari 3
Chiswick 3
Ho Chi Minh City 3
Jinan 3
Kent 3
Kocaeli 3
Lincoln 3
Mombaruzzo 3
Moscow 3
San Jose 3
Selargius 3
Totale 5.033
Salva come PNG Salva come JPEG
Nome #
The perception of stress in cat owners 221
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen. Leuk Lymphoma 196
Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment 166
Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study. 164
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines 159
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen 156
The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia 151
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia 144
A PRACTICAL APPROACH TO THERAPEUTIC DRUG MONITORING OF IMATINIB IN PATIENTS AFFECTED BY CHRONIC MYELOID ELEUKEMIA. THE TIKLET PROTOCOL. 143
Polycomb genes are associated with response to imatinib in chronic myeloid leukemia 140
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 137
Combined unfavourable polymorphisms ofhOCT1 and ABCG2 are responsible for delayed complete cytogenetic response during imatinib treatment. 137
Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders. 137
Reduced circulating B-lymphocytes and altered B-cell compartments in patients suffering from chronic myeloid leukaemia undergoing therapy with Imatinib 136
TCR REARRANGEMENTS ARE NOT ENOUGH FOR DISTINGUISHING THE CHURG-STRAUSS SYNDROME FROM THE HYPEREOSINOPHILIC SYNDROME 132
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines 131
PLATELET-DERIVED GROWTH FACTOR BETA RECEPTOR (PDGFRB) GENE IS REARRANGED IN A SIGNIFICANT PERCENTAGE OF MYELODYSPLASTIC SYNDROMES WITH NORMAL KARYOTYPE 131
Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis 129
MDS: An Integrated Workup for a Correct Diagnosis 127
Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: The FIL FOLL05 trial 126
Transmembrane Transporters hOCT1 and SLCO1B3 Polymorphisms Could Have a Role in Patients Affected By Chronic Myeloid Leukemia Treated with Nilotinib 123
Comparison of Real-Time PCR and Droplet Digital PCR for the Determination of JAK2V617F Mutation in Ph'-Negative Myeloproliferative Neoplasms 117
LOW RPS14 EXPRESSION IS FREQUENTLY FOUND IN NON-5Q-MYELODYSPLASTIC SYNDROMES 117
High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation 115
The WNT pathway is relevant for the BCR-ABL1-independent resistance in chronic myeloid leukemia 115
Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients 114
Droplet digital PCR represents a new sensitive method for detecting B-RAFV600E mutation at diagnosis and during the follow-up of patients affected by hairy cell leukemia 114
Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup 112
The combination of rituximab and bendamustine as first-line treatment is highly effective in the eradicating minimal residual disease in follicular lymphoma: An Italian retrospective study 112
Molecular detection of GNNK- and GNNK+ c-kit isoforms: a new tool for risk stratification in adult acute myeloid leukaemia 109
Increased values of the circulating PDGFβ sustains the "withdrawal syndrome" after tyrosine kinase inhibitor discontinuation in patients affected by chronic myeloid leukemia 106
Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation 105
A Novel Digital PCR Assay for MYD88 L265P Mutation Detection in Waldenstrom Macroglobulinemia: Minimal Residual Disease Monitoring and Characterization on Circulating Free DNA 105
Combined FAMD and ANOVA investigation leads to significant association between the hOCT1/ABCB1 diplotype and both efficacy and tolerability in patients affected by chronic myeloid leukemia 105
WT1 expression levels at diagnosis could predict long-term time-to-progression in adult patients affected by acute myeloid leukaemia and myelodysplastic syndromes 104
Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab 103
Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line 101
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EGPA FROM HES 100
The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia 91
PRDI-BF1 and PRDI-BF1P isoform expressions correlate with disease status in multiple myeloma patients 90
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EOSINOPHILOIA IN EGPA FROM HES 88
Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients 87
Myelodysplastic Syndromes: A Multidisciplinary Integrated Diagnostic Work-up for Patients' Risk Stratification 87
The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients 86
The clinical relevance of the expression of several multidrug-resistant-related genes in patients with primary acute myeloid leukemia 85
ITF2357 interferes with apoptosis and inflammatory pathways in the HL-60 model: a gene expression study. 85
Platelet-derived growth factor beta receptor (PDGFRB) gene is rearranged in a significant percentage of myelodysplastic syndromes with normal karyotype 85
ZINC ORAL SUPPLEMENTATION INDUCES A SIGNIFICANT RISE OF TRECS AND T CD4+ NAΪVE AND PREVENTS THE INCREASE OF TTV VIRAL LOAD AFTER STEM CELL TRANSPLANTATION: THE ZENITH STUDY 85
The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice 84
Conventional Cytogenetics, ACGH, and PCR as Integrated Workup for a Correct Diagnosis of MDS 81
R-IPSS, RPS14 AND WT1 LEVELS ARE THE BEST PROGNOSTIC FACTORS FOR PATIENTS AFFECTED BY MYELODYSPLASTIC SYNDROMES DURING AZACITIDINE TREATMENT. 78
FLT3 mutations do not influence MDR-1 gene expression in acute myeloid leukemia 78
Altered Expression of Jak-Stat Pathway as Possible Predictive Marker in Patients Affected by Chronic Myeloid Leukemia Receiving Tyrosin Kinase Inhibitors (TKIS) 78
THE C.480C>G POLYMORPHISM OF HOCT1 TRANSPORTER INFLUENCES IMATINIB CLEARANCE IN PATIENTS AFFECTED BY CHRONIC MYELOID LEUKEMIA 77
The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma 75
Quantitative molecular evaluation of minimal residual disease in patients with chronic lymphocytic leukemia: efficacy of in vivo purging by alemtuzumab (Campath-1H). 74
Real-Time PCR and Droplet Digital PCR: two techniques for detection of the JAK2(V617F) mutation in Philadelphia-negative chronic myeloproliferative neoplasms 69
Sorafenib Induced Complete Cytogenetic and Molecular Response in a Chronic Eosinophilic Leukemia Case with t(12;13) Translocation 69
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2 66
Digital droplet PCR is a specific and sensitive tool for detecting IDH2 mutations in acute myeloid leukemia patients 65
Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia 63
TYROSINE KINASE INHIBITORS SIGNIFICANTLY CHANGE THE EXPRESSION OF POLYCOMB GENES IN CHRONIC MYELOID LEUKEMIA 62
molecular evaluation of minimal residual disease in multiple myeloma 52
quantitative molecular detection of IgH rearrangement in multiple myeloma: comparison of two innovative techniques 44
Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool 24
A new digital droplet PCR method for looking at epigenetics in diffuse large B‐cell lymphomas: The role of BMI1, EZH2, and USP22 genes 11
Totale 6.959
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.978
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.978
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020559 0 0 0 0 0 0 114 84 97 107 99 58
2020/2021570 31 40 20 19 38 31 42 44 64 45 54 142
2021/2022859 30 42 13 64 144 117 30 32 70 29 70 218
2022/20231.062 159 210 68 72 86 116 8 85 168 6 79 5
2023/2024691 59 54 97 40 77 120 37 19 9 44 22 113
2024/2025823 11 75 15 131 258 243 90 0 0 0 0 0
Totale 6.959